3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
7
Colonic Neoplasms
5
Rectal Neoplasms
4
Colorectal Neoplasms, Hereditary Nonpolyposis
4
Breast Neoplasms
4
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Endometrial Neoplasms
3
Urogenital Neoplasms
2
Prostatic Neoplasms
2
Brain Neoplasms
2
Pancreatic Ductal Adenocarcinoma
1
Neoplastic Syndromes, Hereditary
1
Neoplasms, Unknown Primary
1
Liver Neoplasms
1
Hereditary Breast and Ovarian Cancer Syndrome
1
Head and Neck Neoplasms
1
Genetic Predisposition to Disease
1
Digestive System Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Intraductal, Noninfiltrating
1
Carcinoma, Hepatocellular
1
Anus Neoplasms
1
Interventions
Gemcitabine
4
130-nm albumin-bound paclitaxel
3
Pancreaticoduodenectomy
2
Oxaliplatin
2
Irinotecan
2
titanium silicide
1
tislelizumab
1
sonidegib
1
paricalcitol
1
mitazalimab
1
lenvatinib
1
ivosidenib
1
irinotecan sucrosofate
1
glucoraphanin
1
devimistat
1
Transurethral Resection of Prostate
1
Tissue Banks
1
Taxes
1
Specimen Handling
1
Saline Solution
1
S 1 (combination)
1
Ropivacaine
1
Robotic Surgical Procedures
1
Radiomics
1
Positron Emission Tomography Computed Tomography
1
Parturition
1
PEGPH20
1
Neoadjuvant Therapy
1
Magnetic Resonance Spectroscopy
1
Losartan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pancreatic Ductal Adenocarcinoma
×
Genetic Testing
×
Gastrointestinal
×
Clear all
NCT06574620
2026-01-16
ACCELERATE
British Columbia Cancer Agency
Phase NA
Recruiting
200 enrolled